AI to help heart patients avoid bleeding risks after stents
NCT ID NCT05369442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 1,300 people with coronary artery disease who have a high risk of bleeding after getting a heart stent. Researchers will use artificial intelligence to analyze which blood-thinning drugs and treatment lengths work best to prevent serious bleeding and heart attacks. The goal is to create a safer, more personalized approach to antiplatelet therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antiplatelet drugs
What this could lead to
If successful, this could lead to a personalized antiplatelet treatment plan that reduces bleeding risk after heart stent procedures.
What could go wrong
This is an observational study, not a controlled trial, so it can show patterns but not prove which treatment is best. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital, Sichuan University
RECRUITINGSichuan, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••